Sinorda Biomedicine Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

Sinorda Biomedicine General Information

Description

Developer of biomedicine intends to advance innovative treatments for digestive diseases. The company focuses on the development and innovation of medicine and the industrialization of tumor immunotherapy through its medicine research and development system and medicine production lines in clinical trial stage.

Contact Information

Website
www.sinorda.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 13th Floor, Building 3, Western R&D Base
  • National High-tech Zone
  • Guiyang, Guizhou 550018
  • China
+86 0851
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 13th Floor, Building 3, Western R&D Base
  • National High-tech Zone
  • Guiyang, Guizhou 550018
  • China
+86 0851

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sinorda Biomedicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 09-Jun-2025 Completed Generating Revenue
3. Later Stage VC 21-Nov-2019 Completed Generating Revenue
2. Early Stage VC 29-Jul-2019 Completed Generating Revenue
1. Seed Round 05-Jan-2015 Completed Startup
To view Sinorda Biomedicine’s complete valuation and funding history, request access »

Sinorda Biomedicine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sinorda Biomedicine Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Guizhou Financial Holdings Group Government Minority
Button Capital Venture Capital Minority
KKM Capital Corporation Minority
Guiyang Venture Capital Growth/Expansion Minority
To view Sinorda Biomedicine’s complete investors history, request access »

Sinorda Biomedicine Acquisitions (1)

Sinorda Biomedicine’s most recent deal was a Merger/Acquisition with SentoClone. The deal was made on 01-Jan-2010.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SentoClone 01-Jan-2010 Merger/Acquisition Drug Discovery
To view Sinorda Biomedicine’s complete acquisitions history, request access »

Sinorda Biomedicine FAQs

  • When was Sinorda Biomedicine founded?

    Sinorda Biomedicine was founded in 2010.

  • Where is Sinorda Biomedicine headquartered?

    Sinorda Biomedicine is headquartered in Guiyang, China.

  • What is the size of Sinorda Biomedicine?

    Sinorda Biomedicine has 5 total employees.

  • What industry is Sinorda Biomedicine in?

    Sinorda Biomedicine’s primary industry is Drug Discovery.

  • Is Sinorda Biomedicine a private or public company?

    Sinorda Biomedicine is a Private company.

  • What is Sinorda Biomedicine’s current revenue?

    The current revenue for Sinorda Biomedicine is .

  • Who are Sinorda Biomedicine’s investors?

    Guizhou Financial Holdings Group, Button Capital, KKM Capital, and Guiyang Venture Capital have invested in Sinorda Biomedicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process